IP Library Assignment 074174/0183
Patent Assignment
Reel/Frame 074174/0183

Release of Security Interest in Intellectual Property

Recorded: 2026-01-02 Pages: 75
Assignor
Assignees
MESOBLAST LIMITED
LEVEL 38, 55 COLLINS STREET, MELBOURNE, 3000, AUSTRALIA
MESOBLAST UK LIMITED
5 NEW STREET SQUARE, LONDON, EC4A 3TW, UNITED KINGDOM
MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.)
W. R. GRACE BUILDING, 1114 6TH AVENUE, 4TH FLOOR, NEW YORK, NEW YORK, 10036
MESOBLAST INTERNATIONAL SÀRL
ROUTE DE PRE-BOIS 20, C/O ACCOUNTING & MANAGEMENT SERVICES SA, MEYRIN, 1217, SWITZERLAND
Covered Properties (78)
Isolation of Adult Multipotential Cells by Tissue Non-Specific Alkaline Phosphatase
Application: 16/867,252 →
Publication: US US20200332023A1
Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof
Application: 17/369,147 →
Publication: US US20210355447A1
Treatment of Excessive Neovascularization
Application: 15/788,438 →
Publication: US US20180369286A1
Methods of Generating, Repairing and/or Maintaining Connective Tissue in Vivo
Application: 16/585,911 →
Publication: US US20200101118A1
Repair and/or Reconstitution of Invertebral Discs
Application: 14/504,308 →
Publication: US US20150044186A1
Production of Reprogrammed Pluripotent Cells
Application: 15/299,088 →
Publication: US US20170037377A1
Method of Treating Graft Versus Host Disease
Application: 17/077,698 →
Publication: US US20210085723A1
Methods of Treating or Preventing Neurological Diseases
Application: 17/177,065 →
Publication: US US20210169940A1
Method of Treating the Effects of Stroke
Application: 17/194,855 →
Publication: US US20210228639A1
Methods of Treating or Preventing Respiratory Conditions
Application: 16/889,354 →
Publication: US US20200289578A1
Treatment of Diseases of Endothelial Dysfunction and Inflammation
Application: 14/650,172 →
Publication: US US20160175360A1
Stem Cell Composition
Application: 16/434,726 →
Publication: US US20190345452A1
Treatment of Immune Disorders
Application: 16/828,121 →
Publication: US US20200281984A1
Method for Treating Heart Failure
Application: 15/534,371 →
Publication: US US20170333482A1
Prevention of Progressive Heart Failure
Application: 15/534,376 →
Publication: US US20170340674A1
Cell Culture Method for Mesenchymal Stem Cells
Application: 16/599,271 →
Publication: US US20200040303A1
Potency Assay
Application: 15/571,178 →
Publication: US US20200140822A1
Methods and Apparatus for Separating Cells from Microcarriers
Application: 15/575,160 →
Publication: US US20180142201A1
Mesenchymal Lineage Precursor or Stem Cells with Enhanced Immunosuppression
Application: 16/607,293 →
Publication: US US20200325450A1
Use of mesenchymal lineage precursor cells or stem cells (MLPSCs) for delivery of oligonucleotides in the treatment of cancer
Application: 16/766,206 →
Publication: US US20210163932A1
Expansion of Hematopoietic Stem Cells
Application: 17/286,972 →
Publication: US US20210388319A1
Method for Treating Lower Back Pain
Application: 17/420,314 →
Publication: US US20220143097A1
Method for Improving Visual Acuity
Application: 17/420,325 →
Publication: US US20220079991A1
Method for Treating or Preventing Gastrointestinal Bleeding
Application: 17/425,893 →
Publication: US US20220160776A1
Mesenchymal Stem Cells and Uses Therefor
Application: 16/214,485 →
Publication: US US20190240259A1
Mesenchymal Stem Cells Expressing TNF-alpha Receptors
Application: 17/087,124 →
Publication: US US20210171913A1
Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions
Application: 16/694,382 →
Publication: US US20200197444A1
Enhanced Msc Preparations
Application: 16/725,677 →
Publication: US US20200231936A1
Mesenchymal Precursor Cell
Patent: 7,122,178 →
Application: 10/030,411 →
Mesenchymal Precursor Cell
Patent: 7,670,628 →
Application: 10/813,747 →
Publication: US US20050019911A1
Mesenchymal Precursor Cell
Patent: 8,158,118 →
Application: 11/169,875 →
Publication: US US20050281790A1
Perivascular Mesenchymal Precursor Cells
Patent: 7,947,266 →
Application: 10/551,162 →
Publication: US US20070065938A1
Perivascular Mesenchymal Precursor Cells
Application: 14/746,960 →
Publication: US US20170204373A9
Method of Increasing Proliferation of Bone Marrow Mononuclear Cells Expressing STRO1-Dim
Application: 14/470,769 →
Publication: US US20150072422A1
Isolation of Adult Multipotential Cells by Tissue Non-Specific Alkaline Phosphatase
Patent: 8,367,405 →
Application: 11/918,593 →
Publication: US US20090074728A1
Isolation of Adult Multipotential Cells by Tissue Non-Specific Alkaline Phosphatase
Patent: 9,783,617 →
Application: 15/167,934 →
Publication: US US20160264683A1
Perivascular Mesenchymal Precursor Cell Induced Blood Vessel Formation
Patent: 9,169,466 →
Application: 10/551,326 →
Publication: US US20060286077A1
Perivascular mesenchymal precursor cell induced blood vessel formation
Patent: 9,175,267 →
Application: 11/326,736 →
Publication: US US20060193840A1
Methods of Generating, Repairing and/or Maintaining Connective Tissue in Vivo
Patent: 9,381,216 →
Application: 12/452,767 →
Publication: US US20100203020A1
Repair and/or Reconstitution of Invertebral Discs
Patent: 8,858,932 →
Application: 13/000,721 →
Publication: US US20110189138A1
Expansion of Haemopoietic Precursors
Patent: 8,828,375 →
Application: 13/061,693 →
Publication: US US20110217263A1
Expansion of Haemopoietic Precursors
Patent: 9,415,072 →
Application: 14/476,467 →
Publication: US US20150202232A1
Monoclonal Antibody Stro-4
Patent: 9,090,678 →
Application: 13/059,448 →
Publication: US US20110189696A1
Monoclonal Antibody Stro-4
Patent: 9,815,896 →
Application: 14/795,449 →
Publication: US US20150307608A1
Method for Treating or Preventing a Pancreatic Dysfunction
Patent: 8,894,972 →
Application: 13/129,180 →
Publication: US US20110243902A1
Method for Treating Diabetic Renal Failure or Syndrome X
Patent: 9,480,713 →
Application: 14/535,827 →
Publication: US US20150064148A1
Method for Treating or Preventing a Pancreatic Dysfunction
Patent: 9,968,640 →
Application: 15/336,234 →
Publication: US US20170042945A1
Production of Reprogrammed Pluripotent Cells
Patent: 9,487,756 →
Application: 13/257,233 →
Publication: US US20120121548A1
Method of Treating Graft Versus Host Disease
Patent: 9,301,978 →
Application: 13/808,093 →
Publication: US US20130171113A1
Method of Treating Graft Versus Host Disease
Application: 15/055,221 →
Publication: US US20160361363A1
Method of Treating Graft Versus Host Disease
Application: 16/131,975 →
Publication: US US20190030080A1
Methods of Treating or Preventing Rheumatic Disease
Patent: 9,265,796 →
Application: 14/130,647 →
Publication: US US20140271567A1
Methods of Treating or Preventing Rheumatic Disease
Patent: 9,974,812 →
Application: 14/992,487 →
Publication: US US20160199415A1
Methods of Treating or Preventing Rheumatic Disease
Application: 15/954,768 →
Publication: US US20180303879A1
Methods for Treating Obesity and/or Metabolic Syndrome
Patent: 9,388,385 →
Application: 14/118,862 →
Publication: US US20140294775A1
Methods for Treating Obesity and/or Metabolic Syndrome
Application: 15/176,741 →
Publication: US US20170119822A1
Methods of Treating Multiple Sclerosis Using Stro-1+ and Tnap+ Multipotential Cells
Application: 14/123,758 →
Publication: US US20140322276A1
Methods for Increasing Osteoblastic Function
Patent: 9,642,878 →
Application: 14/343,730 →
Publication: US US20140363404A1
Methods for Increasing Osteoblastic Function
Application: 16/460,734 →
Publication: US US20190343887A1
Methods of Treating or Preventing Respiratory Conditions
Application: 14/650,171 →
Publication: US US20150306146A1
Methods of Treating or Preventing Respiratory Conditions
Application: 16/036,402 →
Publication: US US20190046575A1
Improved Stem Cell Composition
Application: 15/300,716 →
Publication: US US20170107495A1
Treatment of Immune Disorders
Application: 15/317,673 →
Publication: US US20170106023A1
Mesenchymal Stem Cells and Uses Therefor
Patent: 9,943,547 →
Application: 14/087,830 →
Publication: US US20140154276A1
Mesenchymal Stem Cells and Uses Therefor
Patent: 9,694,035 →
Application: 14/334,128 →
Publication: US US20150017132A1
Mesenchymal Stem Cells and Uses Therefor
Application: 14/138,577 →
Publication: US US20140161776A1
Mesenchymal Stem Cells and Uses Therefor
Application: 16/204,936 →
Publication: US US20190175657A1
Mesenchymal Stem Cells and Uses Therefor
Application: 16/206,235 →
Publication: US US20190201447A1
Mesenchymal Stem Cells and Uses Therefor
Application: 16/811,900 →
Publication: US US20200246387A1
Mesenchymal Stem Cells and Uses Therefor
Application: 16/815,784 →
Publication: US US20200360442A1
Mesenchymal Stem Cells Expressing TNF-alpha Receptors
Patent: 8,486,695 →
Application: 13/402,498 →
Publication: US US20120214178A1
Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions
Patent: 8,637,004 →
Application: 12/541,282 →
Publication: US US20100068191A1
Enhanced Msc Preparations
Patent: 9,828,586 →
Application: 14/138,265 →
Publication: US US20140112893A1
Enhanced Msc Preparations
Patent: 9,963,678 →
Application: 14/662,344 →
Publication: US US20150247122A1
Enhanced Msc Preparation
Application: 15/945,148 →
Publication: US US20180291347A1
Protease-Resistant Mutants of Stromal Cell Derived Factor-1 in the Repair of Tissue Damage
Patent: 9,308,277 →
Application: 13/029,891 →
Publication: US US20110224139A1
Protease-Resistant Mutants of Stromal Cell Derived Factor-1 in the Repair of Tissue Damage
Application: 15/054,456 →
Publication: US US20160375100A1
Methods for Repairing Tissue Damage Using Protease-Resistant Mutants of Stromal Cell Derived Factor-1
Application: 14/124,187 →
Publication: US US20140199304A1
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 27, 2017
From: RAKOCZY, PIROSKA ELIZABETH
To: VISOGENE PTY LTD
Reel/Frame 043970/0856 →
Assignment of Assignor's Interest Oct 30, 2017
From: VISOGENE PTY LTD
To: ANGIOBLAST SYSTEMS, INC.
Reel/Frame 043984/0157 →
Change of Name Oct 31, 2017
From: ANGIOBLAST SYSTEMS, INC.
To: MESOBLAST, INC.
Reel/Frame 044637/0898 →
Assignment of Assignor's Interest Nov 16, 2017
From: ITESCU, SILVIU; GOLDEN, LEE
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 044152/0863 →
Assignment of Assignor's Interest Nov 21, 2017
From: ITESCU, SILVIU; GOLDEN, LEE
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 044191/0482 →
Assignment of Assignor's Interest Dec 15, 2017
From: SIMMONS, PAUL; SUIRE, COLBY; SEE, FIONA
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 044408/0566 →
Assignment of Assignor's Interest Dec 15, 2017
From: DAVIDZON, NORMAND; SIMMONS, PAUL
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 044408/0499 →
Intellectual Property Security Agreement Mar 28, 2018
From: MESOBLAST INTERNATIONAL SARL
To: HERCULES CAPITAL, INC., AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 045759/0917 →
Intellectual Property Security Agreement Mar 28, 2018
From: MESOBLAST, INC.
To: HERCULES CAPITAL, INC., AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 045759/0682 →
Assignment of Assignor's Interest Jun 10, 2019
From: ITESCU, SILVIU; SIMMONS, PAUL
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 049420/0740 →
Assignment of Assignor's Interest Sep 30, 2019
From: GHOSH, PETER
To: ANGIOBLAST SYSTEMS, INC.
Reel/Frame 050565/0378 →
Change of Name Sep 30, 2019
From: ANGIOBLAST SYSTEMS, INC.
To: MESOBLAST, INC.
Reel/Frame 050583/0751 →
Assignment of Assignor's Interest Oct 15, 2019
From: SIMMONS, PAUL; SUIRE, COLBY
To: MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 050719/0520 →
Assignment of Assignor's Interest Feb 6, 2020
From: ITESCU, SILVIU; SIMMONS, PAUL
To: MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 051740/0220 →
Assignment of Assignor's Interest Mar 31, 2020
From: ITESCU, SILVIU; SIMMONS, PAUL
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 052270/0385 →
Assignment of Assignor's Interest May 14, 2020
From: GRONTHOS, STAN; ZANNETTINO, ANDREW CHRISTOPHER WILLIAM; SIMMONS, PAUL JOHN
To: MESOBLAST, INC.
Reel/Frame 052667/0167 →
Change of Name May 14, 2020
From: ANGIOBLAST SYSTEMS, INC.
To: MESOBLAST, INC.
Reel/Frame 052672/0900 →
Assignment of Assignor's Interest Jun 2, 2020
From: ITESCU, SILVIU; KRISHNAN, RAVI; GHOSH, PETER
To: MESOBLAST, INC.
Reel/Frame 052810/0768 →
Assignment of Assignor's Interest Oct 23, 2020
From: ITESCU, SILVIU; SCHUSTER, MICHAEL DAVID
To: MESOBLAST, INC.
Reel/Frame 054152/0438 →
Assignment of Assignor's Interest Feb 18, 2021
From: BERNARD, CLAUDE
To: MESOBLAST, INC.
Reel/Frame 055322/0111 →
Change of Name Jul 9, 2021
From: ANGIOBLAST SYSTEMS, INC.
To: MESOBLAST, INC.
Reel/Frame 056819/0765 →
Assignment of Assignor's Interest Jul 9, 2021
From: GRONTHOS, STAN; ZANNETTINO, ANDREW CHRISTOPHER WILLIAM
To: ANGIOBLAST SYSTEMS, INC.
Reel/Frame 056805/0297 →
Security Interest Dec 10, 2021
From: MESOBLAST LIMITED ACN 109 431 870; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058957/0447 →
Assignment of Assignor's Interest Dec 28, 2021
From: ITESCU, SILVIU; SIMMONS, PAUL
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 058492/0562 →
Assignment of Assignor's Interest Apr 12, 2023
From: BRINK, PETER; COHEN, IRA; LIN, RICHARD; DORONIN, SERGEY
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 063311/0001 →